The cystic fibrosis care model is evolving to support people living longer with CF and their increasingly diverse health needs. Catalyzed by the approval of Trikafta® and the COVID-19 pandemic, this adaptive and personalized care model encompasses novel ways to connect clinicians and patients.
Site Search
Showing 1 - 5 of 5 results
News
|
Aug. 9, 2022
|
4 min read
A transformative leader for more than two decades, Marshall will transition to advisory role
News
|
March 6, 2024
|
3 min read
The funding will help support research into the development of potential new modulator therapies for people with cystic fibrosis with an F508del mutation.
News
|
March 7, 2024
|
2 min read
Funding will support a Phase 2b trial of phage therapy for chronic Pseudomonas aeruginosa lung infections.
News
|
March 18, 2024
|
2 min read
This year’s program marked the largest in-person advocacy event in the Foundation’s history.
News
|
March 19, 2024
|
3 min read